Expression of apoptosis-related markers in malignant epithelial tumours of the lacrimal gland and their relation to clinical outcome

British Journal of Ophthalmology

Volumn 91, Issue 9, 2007, Pages 1239-1243

  Strianese, Diego ^a   Baldi, Gianluca ^b   Staibano, Stefania ^a   Baldi, Alfonso ^c   De Rosa, Gaetano ^a   Tranfa, Fausto ^a   Bonavolontà, Giulio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Ospedale di Nocera Inferiore   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN P53;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LACRIMAL GLAND TUMOR; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; EYE NEOPLASMS; FEMALE; HUMANS; IN SITU NICK-END LABELING; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548356560     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.118661     Document Type: Article

References (27)

1. Rootman JA. Disease of the orbit. A multidisciplinary approach. Philadelphia: Lippincott, 1988.
2. Shields CL, Shields JA, Eagle RC, et al. Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology 1989;96:431-5.
3. Zimmerman LE, Sanders TE, Ackerman LV. Epithelial tumors of the lacrimal gland; prognostic and therapeutic significance of histological types. Int Ophthalmol Clin 1962;2:337-67.
4. Forrest AW. Pathological criteria for effective management of epithelial lacrimal gland tumors. Am J Ophthalmol 1971;71:178-92.
5. Wright JE, Stewart WB, Krohel GB. Clinical presentation and management of lacrimal gland tumors. Br J Ophthalmol 1979;63:600- 6.
6. Wright JE. Factors affecting the survival of patients with lacrimal gland tumors. Can J Ophthalmol 1982;17:3-9.
7. Wright JE, Rose GE, Garner A. Primary malignant neoplasms of the lacrimal gland. Br J Ophthalmol 1992;76:401-7.
8. Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland, a clinicopathological study of 21 cases. Arch Ophthalmol 1998;116:613-16.
9. Paulino AF, Huvos AG. Epithelial tumors of the lacrimal glands, a clinicopathological study. Ann Diagn Pathol 1999;3:199-204.
10. Tellado MV, McLean IW, Specht CS, et al. Adenoid cystic carcinomas of the lacrimal gland in childhood and adolescence. Ophthalmology 1997;104:1622-5.
11. Khalil M, Arthurs B. Basal cell carcinoma of the lacrimal gland. Ophthalmology 2000;107:164-8.
12. Salomon RN, Diaz-Cano S. Introduction to apoptosis. Diagn Mol Pathol 1995;4:235-8.
13. Canman CE, Kastan MB. Induction of apoptosis by tumor suppressor genes and oncogenes. Semin Cancer Biol 1995;6:17-25.
14. Schmitt CA, Lowe S. Apoptosis and therapy. J Pathol 1999;187:136-49.
15. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol 1991;7:3111-20.
16. Katsikis PD, Leben WR. Apoptosis. Nature 1995;374:670.
17. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
18. Baldi A, Calia E, Ciampini A, et al. Deafferentation- induced apoptosis of neurons in thalamic somatosensory nuclei of the newborn rat: critical period and rescue from cell death by peripherally applied neurotrophins. Eur J Neurosi 2000;12:2281-90.
19. Hoehner JC, Gestblom C, Olsen L, et al. Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma. Br J Cancer 1997;75:1185-94.
20. Basolo F, Pollina L, Fontanini G, et al. Apoptosis and proliferation in thyroid carcinoma, correlation with bcl-2 and p53 protein expression. Br J Cancer 1997;75:537-41.
21. Paradiso A, Simone G, De Lena M, et al. Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer. Br J Cancer 2001;84:651-8.
22. Greenblatt MS, Bennet WP, Hollstein M, et al. Mutations in the p53 tumor-suppressor gene, clues to cancer etiology and molecular pathogenesis. Cancer Res, 1994;54, 4855-78.
23. Lane DP. A death in the life of p53. Nature 1993;362:786-7.
24. Hall PA, Lane DP. p53 in tumor pathology, can we trust immunohistochemistry? J Pathol 1994;172:1-4.
25. Hrynchak M, White V, Berean K, et al. Cytogenetic findings in seven lacrimal gland neoplasms. Cancer Genet Cytogenet 1994;75:133-8.
26. Soini Y, Tormanern U, Paakko P. Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumors. Histopathology 1998;32:28-34.
27. Yin HF, Okada N, Takagi M. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol Int 2000;50:603-9.